$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 ... 10 11 12 13 14 15 16 17 17 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.60 | 200 | 3,120 | 106,230 | 106.4 K to 106.2 K (-0.19 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.64 | 100 | 1,564 | 106,430 | 106.5 K to 106.4 K (-0.09 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.69 | 100 | 1,569 | 106,530 | 106.6 K to 106.5 K (-0.09 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.70 | 100 | 1,570 | 106,630 | 106.7 K to 106.6 K (-0.09 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.75 | 100 | 1,575 | 106,730 | 106.8 K to 106.7 K (-0.09 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.76 | 500 | 7,880 | 106,830 | 107.3 K to 106.8 K (-0.47 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.77 | 400 | 6,308 | 107,330 | 107.7 K to 107.3 K (-0.37 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.78 | 200 | 3,156 | 107,730 | 107.9 K to 107.7 K (-0.19 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.80 | 100 | 1,580 | 107,930 | 108 K to 107.9 K (-0.09 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.81 | 400 | 6,324 | 108,030 | 108.4 K to 108 K (-0.37 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.82 | 100 | 1,582 | 108,430 | 108.5 K to 108.4 K (-0.09 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.87 | 500 | 7,935 | 108,530 | 109 K to 108.5 K (-0.46 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.88 | 300 | 4,764 | 109,030 | 109.3 K to 109 K (-0.27 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.89 | 100 | 1,589 | 109,330 | 109.4 K to 109.3 K (-0.09 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.92 | 100 | 1,592 | 109,430 | 109.5 K to 109.4 K (-0.09 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.94 | 100 | 1,594 | 109,530 | 109.6 K to 109.5 K (-0.09 %) |
Jan 04 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.99 | 100 | 1,599 | 109,630 | 109.7 K to 109.6 K (-0.09 %) |
Dec 26 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 15.49 | 106,094 | 1,643,396 | 908,581 | |
Dec 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.82 | 1,500 | 23,730 | 37,013 | 38.5 K to 37 K (-3.89 %) |
Dec 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.83 | 500 | 7,915 | 38,513 | 39 K to 38.5 K (-1.28 %) |
Dec 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.85 | 2,000 | 31,700 | 39,013 | 41 K to 39 K (-4.88 %) |
Dec 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.70 | 941 | 14,774 | 41,013 | 42 K to 41 K (-2.24 %) |
Dec 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.90 | 1,000 | 15,900 | 41,954 | 43 K to 42 K (-2.33 %) |
Dec 13 2006 | ACOR | ACORDA THERAPEUTIC ... | YOUNG WISE | Director | Option Exercise | M | 1.56 | 641 | 1,000 | 1,086 | |
Dec 13 2006 | ACOR | ACORDA THERAPEUTIC ... | YOUNG WISE | Director | Buy | M | 1.56 | 641 | 1,000 | 17,307 | 16.7 K to 17.3 K (+3.85 %) |
Dec 12 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.91 | 150 | 2,537 | 42,954 | 43.1 K to 43 K (-0.35 %) |
Dec 12 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.92 | 465 | 7,868 | 43,104 | 43.6 K to 43.1 K (-1.07 %) |
Dec 12 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.93 | 200 | 3,386 | 43,569 | 43.8 K to 43.6 K (-0.46 %) |
Dec 12 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.00 | 350 | 5,950 | 43,769 | 44.1 K to 43.8 K (-0.79 %) |
Dec 12 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.26 | 200 | 3,452 | 44,119 | 44.3 K to 44.1 K (-0.45 %) |
Dec 12 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.84 | 150 | 2,526 | 45,651 | 45.8 K to 45.7 K (-0.33 %) |
Dec 12 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.91 | 200 | 3,382 | 45,801 | 46 K to 45.8 K (-0.43 %) |
Dec 12 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.92 | 700 | 11,844 | 46,001 | 46.7 K to 46 K (-1.50 %) |
Dec 12 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.93 | 250 | 4,233 | 46,701 | 47 K to 46.7 K (-0.53 %) |
Dec 12 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.96 | 750 | 12,720 | 46,951 | 47.7 K to 47 K (-1.57 %) |
Dec 12 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.00 | 450 | 7,650 | 47,701 | 48.2 K to 47.7 K (-0.93 %) |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | YOUNG WISE | Director | Option Exercise | A | 18.65 | 1,086 | 20,254 | 1,727 | |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 18.65 | 1,287 | 24,003 | 5,774 | |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 18.65 | 1,086 | 20,254 | 33,784 | |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Option Exercise | A | 18.65 | 1,206 | 22,492 | 1,206 | |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 18.65 | 1,488 | 27,751 | 34,186 | |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 18.54 | 1,000 | 18,540 | 109,730 | 110.7 K to 109.7 K (-0.90 %) |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 18.80 | 3,000 | 56,400 | 110,730 | 113.7 K to 110.7 K (-2.64 %) |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.07 | 1,000 | 19,070 | 113,730 | 114.7 K to 113.7 K (-0.87 %) |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.15 | 1,500 | 28,725 | 114,730 | 116.2 K to 114.7 K (-1.29 %) |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.25 | 1,000 | 19,250 | 116,230 | 117.2 K to 116.2 K (-0.85 %) |
Dec 01 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | M | 1.56 | 641 | 1,000 | 188,097 | |
Dec 01 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 19.45 | 65 | 1,264 | 48,151 | 48.2 K to 48.2 K (-0.13 %) |
Dec 01 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 19.50 | 200 | 3,900 | 48,216 | 48.4 K to 48.2 K (-0.41 %) |
Dec 01 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 19.51 | 156 | 3,044 | 48,416 | 48.6 K to 48.4 K (-0.32 %) |
Dec 01 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 19.60 | 220 | 4,312 | 48,572 | 48.8 K to 48.6 K (-0.45 %) |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.54 | 1,000 | 18,540 | 260,384 | 261.4 K to 260.4 K (-0.38 %) |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.80 | 2,999 | 56,381 | 261,384 | 264.4 K to 261.4 K (-1.13 %) |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.07 | 999 | 19,051 | 264,383 | 265.4 K to 264.4 K (-0.38 %) |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.15 | 1,593 | 30,506 | 265,382 | 267 K to 265.4 K (-0.60 %) |
Dec 05 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.25 | 1,000 | 19,250 | 266,975 | 268 K to 267 K (-0.37 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.76 | 100 | 1,776 | 44,319 | 44.4 K to 44.3 K (-0.23 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.85 | 100 | 1,785 | 44,419 | 44.5 K to 44.4 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.87 | 100 | 1,787 | 44,519 | 44.6 K to 44.5 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.90 | 100 | 1,790 | 44,619 | 44.7 K to 44.6 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.02 | 200 | 3,604 | 44,719 | 44.9 K to 44.7 K (-0.45 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.09 | 100 | 1,809 | 44,919 | 45 K to 44.9 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.17 | 100 | 1,817 | 45,019 | 45.1 K to 45 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.22 | 58 | 1,057 | 45,119 | 45.2 K to 45.1 K (-0.13 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.63 | 100 | 1,863 | 45,177 | 45.3 K to 45.2 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.92 | 100 | 1,892 | 45,277 | 45.4 K to 45.3 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.97 | 200 | 3,794 | 45,377 | 45.6 K to 45.4 K (-0.44 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.02 | 100 | 1,902 | 45,577 | 45.7 K to 45.6 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.03 | 100 | 1,903 | 45,677 | 45.8 K to 45.7 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.08 | 100 | 1,908 | 45,777 | 45.9 K to 45.8 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.13 | 100 | 1,913 | 45,877 | 46 K to 45.9 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.14 | 200 | 3,828 | 45,977 | 46.2 K to 46 K (-0.43 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.17 | 100 | 1,917 | 46,177 | 46.3 K to 46.2 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.19 | 100 | 1,919 | 46,277 | 46.4 K to 46.3 K (-0.22 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.20 | 200 | 3,840 | 46,377 | 46.6 K to 46.4 K (-0.43 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.21 | 100 | 1,921 | 46,577 | 46.7 K to 46.6 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.22 | 100 | 1,922 | 46,677 | 46.8 K to 46.7 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.23 | 400 | 7,692 | 46,777 | 47.2 K to 46.8 K (-0.85 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.24 | 100 | 1,924 | 47,177 | 47.3 K to 47.2 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.25 | 100 | 1,925 | 47,277 | 47.4 K to 47.3 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.27 | 100 | 1,927 | 47,377 | 47.5 K to 47.4 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.28 | 200 | 3,856 | 47,477 | 47.7 K to 47.5 K (-0.42 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.29 | 100 | 1,929 | 47,677 | 47.8 K to 47.7 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.31 | 400 | 7,724 | 47,777 | 48.2 K to 47.8 K (-0.83 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.32 | 100 | 1,932 | 48,177 | 48.3 K to 48.2 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.34 | 100 | 1,934 | 48,277 | 48.4 K to 48.3 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.37 | 100 | 1,937 | 48,377 | 48.5 K to 48.4 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.37 | 100 | 1,937 | 48,477 | 48.6 K to 48.5 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.39 | 100 | 1,939 | 48,577 | 48.7 K to 48.6 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.40 | 100 | 1,940 | 48,677 | 48.8 K to 48.7 K (-0.21 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.42 | 100 | 1,942 | 48,777 | 48.9 K to 48.8 K (-0.20 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.43 | 100 | 1,943 | 48,877 | 49 K to 48.9 K (-0.20 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.51 | 100 | 1,951 | 48,977 | 49.1 K to 49 K (-0.20 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.57 | 100 | 1,957 | 49,077 | 49.2 K to 49.1 K (-0.20 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.59 | 100 | 1,959 | 49,177 | 49.3 K to 49.2 K (-0.20 %) |
Nov 21 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 19.72 | 100 | 1,972 | 49,277 | 49.4 K to 49.3 K (-0.20 %) |
Nov 14 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 14.96 | 2,000 | 29,920 | 1 | 2 K to 1 (-99.95 %) |
Nov 14 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 14.95 | 11,300 | 168,935 | 2,001 | 13.3 K to 2 K (-84.96 %) |
Nov 14 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 14.90 | 2,413 | 35,954 | 13,301 | 15.7 K to 13.3 K (-15.36 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.13 | 2,051 | 31,032 | 35,764 | 37.8 K to 35.8 K (-5.42 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.14 | 100 | 1,514 | 37,815 | 37.9 K to 37.8 K (-0.26 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.15 | 200 | 3,030 | 37,915 | 38.1 K to 37.9 K (-0.52 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.16 | 300 | 4,548 | 38,115 | 38.4 K to 38.1 K (-0.78 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.17 | 200 | 3,034 | 38,415 | 38.6 K to 38.4 K (-0.52 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.18 | 400 | 6,072 | 38,615 | 39 K to 38.6 K (-1.03 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.19 | 200 | 3,038 | 39,015 | 39.2 K to 39 K (-0.51 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.20 | 400 | 6,080 | 39,215 | 39.6 K to 39.2 K (-1.01 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.21 | 300 | 4,563 | 39,615 | 39.9 K to 39.6 K (-0.75 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.22 | 200 | 3,044 | 39,915 | 40.1 K to 39.9 K (-0.50 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.23 | 100 | 1,523 | 40,115 | 40.2 K to 40.1 K (-0.25 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.32 | 300 | 4,596 | 40,215 | 40.5 K to 40.2 K (-0.74 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.38 | 100 | 1,538 | 40,515 | 40.6 K to 40.5 K (-0.25 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.89 | 100 | 1,489 | 40,615 | 40.7 K to 40.6 K (-0.25 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.91 | 100 | 1,491 | 40,715 | 40.8 K to 40.7 K (-0.25 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.92 | 100 | 1,492 | 40,815 | 40.9 K to 40.8 K (-0.24 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.93 | 200 | 2,986 | 40,915 | 41.1 K to 40.9 K (-0.49 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.94 | 300 | 4,482 | 41,115 | 41.4 K to 41.1 K (-0.72 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.95 | 100 | 1,495 | 41,415 | 41.5 K to 41.4 K (-0.24 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.96 | 221 | 3,306 | 41,515 | 41.7 K to 41.5 K (-0.53 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.99 | 100 | 1,499 | 41,736 | 41.8 K to 41.7 K (-0.24 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.00 | 479 | 7,185 | 41,836 | 42.3 K to 41.8 K (-1.13 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.02 | 200 | 3,004 | 42,315 | 42.5 K to 42.3 K (-0.47 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.05 | 100 | 1,505 | 42,515 | 42.6 K to 42.5 K (-0.23 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.10 | 100 | 1,510 | 42,615 | 42.7 K to 42.6 K (-0.23 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.13 | 500 | 7,565 | 42,715 | 43.2 K to 42.7 K (-1.16 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.24 | 200 | 3,048 | 43,215 | 43.4 K to 43.2 K (-0.46 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.25 | 100 | 1,525 | 43,415 | 43.5 K to 43.4 K (-0.23 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.28 | 200 | 3,056 | 43,515 | 43.7 K to 43.5 K (-0.46 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.29 | 400 | 6,116 | 43,715 | 44.1 K to 43.7 K (-0.91 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.30 | 100 | 1,530 | 44,115 | 44.2 K to 44.1 K (-0.23 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.32 | 100 | 1,532 | 44,215 | 44.3 K to 44.2 K (-0.23 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.33 | 300 | 4,599 | 44,315 | 44.6 K to 44.3 K (-0.67 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.38 | 100 | 1,538 | 44,615 | 44.7 K to 44.6 K (-0.22 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.39 | 200 | 3,078 | 44,715 | 44.9 K to 44.7 K (-0.45 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.41 | 100 | 1,541 | 44,915 | 45 K to 44.9 K (-0.22 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.42 | 100 | 1,542 | 45,015 | 45.1 K to 45 K (-0.22 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.43 | 100 | 1,543 | 45,115 | 45.2 K to 45.1 K (-0.22 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.45 | 100 | 1,545 | 45,215 | 45.3 K to 45.2 K (-0.22 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.45 | 416 | 6,427 | 45,315 | 45.7 K to 45.3 K (-0.91 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.46 | 500 | 7,730 | 45,731 | 46.2 K to 45.7 K (-1.08 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.47 | 484 | 7,487 | 46,231 | 46.7 K to 46.2 K (-1.04 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.48 | 400 | 6,192 | 46,715 | 47.1 K to 46.7 K (-0.85 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.49 | 300 | 4,647 | 47,115 | 47.4 K to 47.1 K (-0.63 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.50 | 700 | 10,850 | 47,415 | 48.1 K to 47.4 K (-1.45 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.56 | 100 | 1,556 | 48,115 | 48.2 K to 48.1 K (-0.21 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.57 | 100 | 1,557 | 48,215 | 48.3 K to 48.2 K (-0.21 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.59 | 200 | 3,118 | 48,315 | 48.5 K to 48.3 K (-0.41 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.60 | 100 | 1,560 | 48,515 | 48.6 K to 48.5 K (-0.21 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.62 | 300 | 4,686 | 48,615 | 48.9 K to 48.6 K (-0.61 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.65 | 100 | 1,565 | 48,915 | 49 K to 48.9 K (-0.20 %) |